Results
|
11201.
|
|
|
11202.
|
|
|
11203.
|
|
|
11204.
|
|
|
11205.
|
|
|
11206.
|
|
|
11207.
|
|
|
11208.
|
|
|
11209.
|
|
|
11210.
|
Phase II study of exatecan mesylate (DX-8951f) as first line therapy for advanced non-small cell lung cancer. [electronic resource] by
- Braybrooke, J P
- Ranson, M
- Manegold, C
- Mattson, K
- Thatcher, N
- Cheverton, P
- Sekiguchi, M
- Suzuki, M
- Oyama, R
- Talbot, D C
Producer: 20031208
In:
Lung cancer (Amsterdam, Netherlands) vol. 41
Availability: No items available.
|
|
11211.
|
|
|
11212.
|
|
|
11213.
|
|
|
11214.
|
|
|
11215.
|
|
|
11216.
|
|
|
11217.
|
|
|
11218.
|
|
|
11219.
|
|
|
11220.
|
|